Form D · Biotechnology
MetaBiotech Corp
San Jose, CA · CIK 0001731460
Offering snapshot reported Feb 14, 2018 · SEC filing
- Reported sold
- $9.18M Offering amount: $10.4M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 30, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 14, 2018 | Initial | $9,177,231 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-305634
Source: Form D, filed Feb 14, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tuval Ben Yehezkel | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5941 Optical Court
San Jose, CA, 95138
San Jose, CA, 95138